DK40487D0 - Heterocycliske lipoxygenaseinhibitorer og farmaceutisk acceptable salte deraf - Google Patents

Heterocycliske lipoxygenaseinhibitorer og farmaceutisk acceptable salte deraf

Info

Publication number
DK40487D0
DK40487D0 DK040487A DK40487A DK40487D0 DK 40487 D0 DK40487 D0 DK 40487D0 DK 040487 A DK040487 A DK 040487A DK 40487 A DK40487 A DK 40487A DK 40487 D0 DK40487 D0 DK 40487D0
Authority
DK
Denmark
Prior art keywords
heterocyclic
acceptable salts
pharmaceutical acceptable
lipoxygenase inhibitors
lipoxygenase
Prior art date
Application number
DK040487A
Other languages
English (en)
Other versions
DK40487A (da
Inventor
John Henry Musser
Dennis Martin Kubrak
Iii Anthony Frank Kreft
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of DK40487D0 publication Critical patent/DK40487D0/da
Publication of DK40487A publication Critical patent/DK40487A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK040487A 1986-01-27 1987-01-26 Heterocycliske lipoxygenaseinhibitorer og farmaceutisk acceptable salte deraf DK40487A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/823,163 US4675405A (en) 1984-09-21 1986-01-27 Quinoline compounds as antiallergic and antithrombotic agents

Publications (2)

Publication Number Publication Date
DK40487D0 true DK40487D0 (da) 1987-01-26
DK40487A DK40487A (da) 1987-07-28

Family

ID=25237976

Family Applications (1)

Application Number Title Priority Date Filing Date
DK040487A DK40487A (da) 1986-01-27 1987-01-26 Heterocycliske lipoxygenaseinhibitorer og farmaceutisk acceptable salte deraf

Country Status (9)

Country Link
US (1) US4675405A (da)
JP (1) JPS62190159A (da)
KR (1) KR900001205B1 (da)
DK (1) DK40487A (da)
FI (1) FI870298A7 (da)
HU (1) HU198021B (da)
PH (1) PH22670A (da)
PT (1) PT84144B (da)
ZA (1) ZA8744B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087380A (en) 1949-11-24 2000-07-11 Boehringer Ingelheim Pharma Kg Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions
US5234942A (en) * 1984-10-19 1993-08-10 Ici Americas Inc. Heterocyclic amides and leucotriene antagonistic use thereof
US4772703A (en) * 1986-01-27 1988-09-20 American Home Products Corporation 2-(phenoxymethyl)-quinazolines as antiallergic and antiinflammatory agents
US4904786A (en) * 1986-01-27 1990-02-27 American Home Products Corporation Quinoline compounds as antiallergic and antiinflammatory agents
GB2185741B (en) * 1986-01-27 1989-10-25 American Home Prod Heterocyclic sulphonamides
FR2594438B1 (fr) * 1986-02-14 1990-01-26 Labaz Sanofi Nv Derives d'indolizine, leur procede de preparation ainsi que les compositions en contenant
US5202336A (en) * 1986-09-24 1993-04-13 Bayer Aktiengesellschaft Antiflammatory quinolin methoxy phenylsulphonamides
DE3632329A1 (de) * 1986-09-24 1988-03-31 Bayer Ag Substituierte phenylsulfonamide
JPH01502755A (ja) * 1987-03-18 1989-09-21 アメリカン・ホーム・プロダクツ・コーポレイション スルホニルカルボキシアミド
IL86462A (en) * 1987-05-29 1992-12-01 Fujisawa Pharmaceutical Co Alkanesulfonanilide derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same
FR2642756B1 (fr) * 1989-02-07 1994-03-04 Sanofi Derives cycloaminoalkoxyphenyle, leur procede de preparation ainsi que les compositions pharmaceutiques ou veterinaires en contenant
FR2642755B1 (da) * 1989-02-07 1993-11-05 Sanofi
WO1990015801A1 (en) * 1989-06-22 1990-12-27 Pfizer Inc. Substituted sulfonamides and related compounds in the treatment of asthma, arthritis and related diseases
AT394045B (de) * 1989-07-05 1992-01-27 Chem Pharm Forsch Gmbh Neue sulfamoyl-thiophene, verfahren zu ihrer herstellung und ihre verwendung
JPH03173874A (ja) * 1989-09-29 1991-07-29 Mitsubishi Kasei Corp 新規複素環化合物
JPH03181465A (ja) * 1989-12-11 1991-08-07 Takeda Chem Ind Ltd キノリン誘導体
DE4219765A1 (de) * 1992-06-17 1993-12-23 Bayer Ag Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenylessigsäurederivate
PE121699A1 (es) * 1997-02-18 1999-12-08 Boehringer Ingelheim Pharma Heterociclos biciclicos disustituidos como inhibidores de la trombina
US6414008B1 (en) * 1997-04-29 2002-07-02 Boehringer Ingelheim Pharma Kg Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions
US20030181488A1 (en) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
DE10339862A1 (de) * 2003-08-29 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel
DE102005025728A1 (de) * 2005-06-04 2006-12-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-Propionsäure-ethylester

Also Published As

Publication number Publication date
HU198021B (en) 1989-07-28
FI870298A0 (fi) 1987-01-23
DK40487A (da) 1987-07-28
HUT44511A (en) 1988-03-28
PH22670A (en) 1988-11-14
PT84144A (en) 1987-02-01
ZA8744B (en) 1988-08-31
FI870298A7 (fi) 1987-07-28
JPS62190159A (ja) 1987-08-20
KR900001205B1 (ko) 1990-02-28
PT84144B (pt) 1989-03-30
KR870007130A (ko) 1987-08-17
US4675405A (en) 1987-06-23

Similar Documents

Publication Publication Date Title
DK40487D0 (da) Heterocycliske lipoxygenaseinhibitorer og farmaceutisk acceptable salte deraf
DK290188A (da) Alkoxysubstituerede dihydrobenzopyran-2-carboxylatderivater og farmaceutiske acceptable salte deraf samt deres anvendelse
DK70491D0 (da) Heterocyklisk renininhibitorer
DK59184A (da) Farmakologisk virksomme forbindelser og terapeutisk acceptable salte deraf
DK543189A (da) Lysyloxidaseinhibitorer og deres anvendelse
DK122291D0 (da) Benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
DK586286A (da) N-substituerede butyramidderivater og salte deraf samt deres fremstilling og anvendelse
DK533589A (da) Pharmaceutisk aktive aminer
DK61887A (da) Substituerede 5-amino-4-hydroxy-valerylderivater og salte deraf samt deres fremstilling og anvendelse
DK114684D0 (da) N-(piperidinyl-alkyl)carboxyamider og salte deraf samt deres fremstilling og anvendelse
DK39988A (da) 4-aryl-n-(2-(dialkylamino og heterocyclisk amino)alkyl)-1-piperazincarboxamider og anvendelsen heraf
DK461389A (da) Quinolyloxazol-2-oner og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
DK483481A (da) Enkephalinderivater og farmaceutisk acceptable salte deraf deres fremstilling og anvendelse
NO885463D0 (no) 4-heteropentacyklisk-4-(n-(fenyl)amido)piperidin-derivater og farmasoeytiske sammensetninger og fremgangsmaater for anvendelse derav.
NO864859L (no) N-(pyrrol-1-yl)pyridinaminer og fremgangsmaate for fremstilling derav.
DK632088A (da) Azacycloalkylalkandiphosphonsyrer og salte deraf
DK713288D0 (da) Anvendelse af katakol-o-metyltransferase-inhibitorer og fysiologisk acceptable salte og estere deraf
DK522888D0 (da) Heterocykliske derivater og farmaceutiske praeparater med indhold af saadanne
DK61386D0 (da) N-substituerede butyramidderivater og salte deraf samt deres fremstilling og anvendelse
DK469879A (da) Adenosintriphosphatderivat og salte deraf
DK4487D0 (da) Heterocycliske forbindelser og farmaceutiske praeparater indeholdende disse
DK79687D0 (da) N-substituerede saframycinderivater og salte deraf samt deres fremstilling og anvendelse
DK166372C (da) Phenethylaminderivater og pharmaceutisk acceptable salte deraf
DK514786A (da) 5-heterocyclyl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner og tautomere og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelsesom antidepressive midler
DK673888D0 (da) Polycycliske imider og farmaceutisk acceptable salte deraf

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment